New ulcerative colitis drug shows early promise in small safety trial
Knowledge-focused
Completed
This early-stage study tested a new drug called NP-201 in 35 healthy adults and people with mild-to-moderate ulcerative colitis. The main goal was to check if the drug is safe and how the body processes it. Researchers gave the drug as a shot under the skin and monitored for side…
Phase: PHASE1 • Sponsor: NIBEC Co., Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC